BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16865235)

  • 1. Quantification of caveolin isoforms using quantitative real-time RT-PCR, and analysis of promoter CpG methylation of caveolin-1alpha in human T cell leukemia cell lines.
    Tsuji Y; Nakagawa T; Hatanaka M; Takeuchi T; Matsumoto E; Takenaka H; Shimizu A
    Int J Mol Med; 2006 Sep; 18(3):489-95. PubMed ID: 16865235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
    Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential-expression and tyrosine-phosphorylation profiles of caveolin isoforms in human T cell leukemia cell lines.
    Tsuji Y; Hatanaka M; Maeda T; Seya T; Takenaka H; Shimizu A
    Int J Mol Med; 2005 Nov; 16(5):889-93. PubMed ID: 16211260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
    Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
    Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells.
    Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R
    J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines.
    Patlolla JM; Swamy MV; Raju J; Rao CV
    Oncol Rep; 2004 May; 11(5):957-63. PubMed ID: 15069532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines.
    Hurlstone AF; Reid G; Reeves JR; Fraser J; Strathdee G; Rahilly M; Parkinson EK; Black DM
    Oncogene; 1999 Mar; 18(10):1881-90. PubMed ID: 10086342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter CpG methylation of caveolin-1 in sporadic colorectal cancer.
    Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chang JG
    Anticancer Res; 2004; 24(3a):1645-50. PubMed ID: 15274335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of caveolin-1 in human T cell leukemia cell lines.
    Hatanaka M; Maeda T; Ikemoto T; Mori H; Seya T; Shimizu A
    Biochem Biophys Res Commun; 1998 Dec; 253(2):382-7. PubMed ID: 9878546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
    Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-1 and -2 in airway epithelium: expression and in situ association as detected by FRET-CLSM.
    Krasteva G; Pfeil U; Drab M; Kummer W; König P
    Respir Res; 2006 Aug; 7(1):108. PubMed ID: 16904002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational, epigenetic and expressional analyses of caveolin-1 gene in cervical cancers.
    Chan TF; Su TH; Yeh KT; Chang JY; Lin TH; Chen JC; Yuang SS; Chang JG
    Int J Oncol; 2003 Sep; 23(3):599-604. PubMed ID: 12888893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation.
    Wethkamp N; Ramp U; Geddert H; Schulz WA; Florl AR; Suschek CV; Hassan M; Gabbert HE; Mahotka C
    Eur J Cancer; 2006 Jan; 42(2):264-74. PubMed ID: 16386893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation.
    Tang H; Goldberg E
    J Androl; 2009; 30(2):157-67. PubMed ID: 18930904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of caveolin 1 gene expression in lung carcinoma cell lines.
    Racine C; Bélanger M; Hirabayashi H; Boucher M; Chakir J; Couet J
    Biochem Biophys Res Commun; 1999 Feb; 255(3):580-6. PubMed ID: 10049753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity.
    Guarcello V; Blanquicett C; Naguib FN; El Kouni MH
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):85-96. PubMed ID: 17805539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.